혈액 도핑 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "혈액 도핑" in Korean language version.

refsWebsite

Global rank Korean rank

29nih.gov

4^th place

28doi.org

2^nd place

3^rd place

10semanticscholar.org

11^th place

310^th place

6archive.org

6^th place

18^th place

3cyclingnews.com

949^th place

low place

2uzh.ch

3,633^rd place

7,734^th place

2worldcat.org

5^th place

11^th place

2books.google.com

3^rd place

9^th place

1harvard.edu

18^th place

27^th place

1mapinc.org

low place

1web.archive.org

1^st place

1la84.org

4,945^th place

low place

1smh.com.au

132^nd place

451^st place

1bbc.co.uk

8^th place

34^th place

1cyclingpost.com

low place

1tsn.ca

1,325^th place

low place

1sueddeutsche.de

226^th place

1,448^th place

1bloomberg.com

99^th place

156^th place

1go.com

48^th place

173^rd place

1bleacherreport.com

262^nd place

2,096^th place

1mmajunkie.com

352^nd place

8,772^nd place

1athleticsintegrity.org

low place

archive.org

Hoffman, Ronald; 외. (2009). 〈68〉. 《Hematology : basic principles and practice》 5판. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 978-0443067150.
Joyner, MJ (Jun 2003). “VO2MAX, blood doping, and erythropoietin”. 《British Journal of Sports Medicine》 37 (3): 190–191. doi:10.1136/bjsm.37.3.190. PMC 1724644. PMID 12782539.
Ghaphery, NA (1995). “Performance-enhancing drugs”. 《Orthop Clin North Am》 26 (3): 433–442. doi:10.1016/S0030-5898(20)32008-3. PMID 7609958.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Pace (January 1947). “The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes.”. 《The American Journal of Physiology》 148 (1): 152–163. doi:10.1152/ajplegacy.1947.148.1.152. PMID 20283143.
Pugliese, David (2002). 《Canada's Secret Commandos》. Ottawa: Esprit de Corps Books. ISBN 978-1-895896-18-3.

athleticsintegrity.org

“First Instance Decisions | Athletics Integrity Unit”.

bbc.co.uk

news.bbc.co.uk

"Vinokourov Fails Tour Doping Test." BBC News. BBC, 24 July 2007. Web. 07 Oct. 2015. http://news.bbc.co.uk/sport2/hi/other_sports/cycling/6914301.stm

bleacherreport.com

Rondina, Steven. “Chael Sonnen Admits Use of HGH, EPO in Response to NSAC Complaint”. 《Bleacher Report》.

bloomberg.com

Novy-Williams, Eben (2011년 5월 20일). “Cyclist Tyler Hamilton Hands in 2004 Olympic Gold Medal to Doping Agency”. 《Bloomberg》.

books.google.com

Arthur J. Sytkowski (May 2006). 《Erythropoietin: Blood, Brain and Beyond》. John Wiley & Sons. 187–쪽. ISBN 978-3-527-60543-9. 2012년 7월 19일에 확인함.
Steven B. Kayne (2006). 《Sport And Exercise Medicine For Pharmacists》. Pharmaceutical Press. 232–쪽. ISBN 978-0-85369-600-1. 2012년 7월 19일에 확인함.

cyclingnews.com

autobus.cyclingnews.com

“The Hamilton decision”. 《Cyclingnews.com》. Future Publishing. 2005년 4월 19일. 2007년 7월 30일에 확인함.
“Kashechkin tests positive for blood doping”. Cyclingnews.com. 2007년 8월 9일에 확인함.

cyclingnews.com

McKay, Fergal (2015년 3월 22일). “A history on the use of blood transfusions in cycling”. 《cyclingnews.com》. 2015년 3월 22일에 확인함.

cyclingpost.com

“Vinokourov also found positive on Monday”. Cyclingpost.com. 2007년 7월 29일에 확인함.

doi.org

dx.doi.org

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Haase, VH (Aug 2006). “Hypoxia-inducible factors in the kidney”. 《American Journal of Physiology. Renal Physiology》 291 (2): F271–281. doi:10.1152/ajprenal.00071.2006. PMC 4232221. PMID 16554418.
Joyner, MJ (Jun 2003). “VO2MAX, blood doping, and erythropoietin”. 《British Journal of Sports Medicine》 37 (3): 190–191. doi:10.1136/bjsm.37.3.190. PMC 1724644. PMID 12782539.
Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.
Görgens, C; Guddat, S; Schänzer, W; Thevis, M (2014). “Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes”. 《Drug Test. Anal.》 6 (11–12): 1102–1107. doi:10.1002/dta.1700. PMID 25070041.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.
Gledhill, N (1982). “Blood doping and related issues: A brief review”. 《Med Sci Sports Exerc》 14 (3): 183–189. doi:10.1249/00005768-198203000-00005. PMID 7109883.
Ghaphery, NA (1995). “Performance-enhancing drugs”. 《Orthop Clin North Am》 26 (3): 433–442. doi:10.1016/S0030-5898(20)32008-3. PMID 7609958.
Scott, MG; Kucik, DF; Goodnough, LT; Monk, TG (1997). “Blood substitutes: Evolution and future applications”. 《Clin Chem》 43 (9): 1724–1731. doi:10.1093/clinchem/43.9.1724. PMID 9299967.
Ma, Z; Monk, TG; Goodnough, LT; McClellan, A; Gawryl, M; Clark, T; Moreira, P; Keipert, PE; Scott, MG (1997). “Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests”. 《Clin Chem》 43 (9): 1732–1737. doi:10.1093/clinchem/43.9.1732. PMID 9299968.
Hughes, GS Jr; Antal, EJ; Locker, PK; Francom, SF; Adams, WJ; Jacobs, EE Jr (1996). “Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans”. 《Crit Care Med》 24 (5): 756–764. doi:10.1097/00003246-199605000-00006. PMID 8706450.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (May 2008). “Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis”. 《JAMA》 299 (19): 2304–2312. doi:10.1001/jama.299.19.jrv80007. PMC 10802128 |pmc= 값 확인 필요 (도움말). PMID 18443023.
Spahn, DR (1999). “Blood substitutes. Artificial oxygen carriers: Perfluorocarbon emulsions”. 《Crit Care》 3 (5): R93–R97. doi:10.1186/cc364. PMC 137239. PMID 11094488.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Lippi, G.; Franchini, M.; Guidi, G. (2005). “Cobalt chloride administration in athletes: a new perspective in blood doping?”. 《Br J Sports Med》 39 (11): 872–873. doi:10.1136/bjsm.2005.019232. PMC 1725077. PMID 16244201.
Jelkmann, W (2007). “Novel Erythropoietic Agents: A Threat to Sportsmanship”. 《Medician Sportiva》 11 (2): 32–34. doi:10.2478/v10036-007-0007-1.
Kanayaa, K.; Kamitania, T. (2003). “pVHL-independent ubiquitination of HIF1a and its stabilization by cobalt ion”. 《Biochemical and Biophysical Research Communications》 306 (3): 750–755. doi:10.1016/s0006-291x(03)01041-6. PMID 12810083.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S.; 외. (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Staub, S.; 외. (2010). “Blood Doping Detection- A New Analytical Approach with Capillary Electrophoresis”. 《CHIMIA》 64 (12): 886. doi:10.2533/chimia.2010.886.
Pace (January 1947). “The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes.”. 《The American Journal of Physiology》 148 (1): 152–163. doi:10.1152/ajplegacy.1947.148.1.152. PMID 20283143.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

go.com

abcnews.go.com

Karlinsky, Neal. "Lance Armstrong Stripped of 7 Tour De France Titles, Banned for Life After Doping Scandal." ABC News. ABC News Network, 22 Oct. 2012. Web. 06 Oct. 2015. [1]

harvard.edu

adsabs.harvard.edu

Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.

la84.org

library.la84.org

“History of Doping in Sport” (PDF). International Sports Studies, Vol 24, Issue 1. 2002. 2017년 11월 23일에 원본 문서 (PDF)에서 보존된 문서. 2016년 10월 26일에 확인함.

mapinc.org

Russell, Ken (1998-09-18). Australia: Troops Get The All-Clear To Dose Up On Energy Drugs. Sydney Morning Herald. Retrieved on 2011-06-01.

mmajunkie.com

“BCAC: Ali Bagautinov tests positive for EPO for UFC 174, suspended one year”. 2014년 7월 10일.

nih.gov

ncbi.nlm.nih.gov

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Haase, VH (Aug 2006). “Hypoxia-inducible factors in the kidney”. 《American Journal of Physiology. Renal Physiology》 291 (2): F271–281. doi:10.1152/ajprenal.00071.2006. PMC 4232221. PMID 16554418.
Joyner, MJ (Jun 2003). “VO2MAX, blood doping, and erythropoietin”. 《British Journal of Sports Medicine》 37 (3): 190–191. doi:10.1136/bjsm.37.3.190. PMC 1724644. PMID 12782539.
Biolo, A; Greferath, R; Siwik, DA; Qin, F; Valsky, E; Fylaktakidou, KC; Pothukanuri, S; Duarte, CD; Schwarz, RP; Lehn, JM; Nicolau, C; Colucci, WS (2009). “Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate”. 《Proc Natl Acad Sci U S A》 106 (6): 1926–1929. Bibcode:2009PNAS..106.1926B. doi:10.1073/pnas.0812381106. PMC 2644140. PMID 19204295.
Görgens, C; Guddat, S; Schänzer, W; Thevis, M (2014). “Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes”. 《Drug Test. Anal.》 6 (11–12): 1102–1107. doi:10.1002/dta.1700. PMID 25070041.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.
Gledhill, N (1982). “Blood doping and related issues: A brief review”. 《Med Sci Sports Exerc》 14 (3): 183–189. doi:10.1249/00005768-198203000-00005. PMID 7109883.
Ghaphery, NA (1995). “Performance-enhancing drugs”. 《Orthop Clin North Am》 26 (3): 433–442. doi:10.1016/S0030-5898(20)32008-3. PMID 7609958.
Scott, MG; Kucik, DF; Goodnough, LT; Monk, TG (1997). “Blood substitutes: Evolution and future applications”. 《Clin Chem》 43 (9): 1724–1731. doi:10.1093/clinchem/43.9.1724. PMID 9299967.
Ma, Z; Monk, TG; Goodnough, LT; McClellan, A; Gawryl, M; Clark, T; Moreira, P; Keipert, PE; Scott, MG (1997). “Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests”. 《Clin Chem》 43 (9): 1732–1737. doi:10.1093/clinchem/43.9.1732. PMID 9299968.
Lieberthal, W; Fuhro, R; Freedman, JE; Toolan, G; Loscalzo, J; Valeri, CR (1999). “O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin”. 《J Pharmacol Exp Ther》 288 (3): 1278–1287. PMID 10027869.
Hughes, GS Jr; Antal, EJ; Locker, PK; Francom, SF; Adams, WJ; Jacobs, EE Jr (1996). “Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans”. 《Crit Care Med》 24 (5): 756–764. doi:10.1097/00003246-199605000-00006. PMID 8706450.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (May 2008). “Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis”. 《JAMA》 299 (19): 2304–2312. doi:10.1001/jama.299.19.jrv80007. PMC 10802128 |pmc= 값 확인 필요 (도움말). PMID 18443023.
Spahn, DR (1999). “Blood substitutes. Artificial oxygen carriers: Perfluorocarbon emulsions”. 《Crit Care》 3 (5): R93–R97. doi:10.1186/cc364. PMC 137239. PMID 11094488.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Lippi, G.; Franchini, M.; Guidi, G. (2005). “Cobalt chloride administration in athletes: a new perspective in blood doping?”. 《Br J Sports Med》 39 (11): 872–873. doi:10.1136/bjsm.2005.019232. PMC 1725077. PMID 16244201.
Kanayaa, K.; Kamitania, T. (2003). “pVHL-independent ubiquitination of HIF1a and its stabilization by cobalt ion”. 《Biochemical and Biophysical Research Communications》 306 (3): 750–755. doi:10.1016/s0006-291x(03)01041-6. PMID 12810083.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S.; 외. (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Pace (January 1947). “The increase in hypoxia tolerance of normal men accompanying the polycythemia induced by transfusion of erythrocytes.”. 《The American Journal of Physiology》 148 (1): 152–163. doi:10.1152/ajplegacy.1947.148.1.152. PMID 20283143.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Blajchman, M (2002). “Incidence and significance of the bacterial contamination of blood components”. 《Dev Biol (Basel)》 108: 59–67. PMID 12220143.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

pubmed.ncbi.nlm.nih.gov

Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.

semanticscholar.org

api.semanticscholar.org

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Buemi, M; Caccamo, C; Nostro, L; Cavallaro, E; Floccari, F; Grasso, G (Mar 2005). “Brain and cancer: the protective role of erythropoietin”. 《Medicinal Research Reviews》 25 (2): 245–259. doi:10.1002/med.20012. PMID 15389732. S2CID 46380760.
Hughes, GS Jr; Yancey, EP; Albrecht, R; Locker, PK; Francom, SF; Orringer, EP; Antal, EJ; Jacobs, EE Jr (1995). “Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans”. 《Clin Pharmacol Ther》 58 (4): 434–443. doi:10.1016/0009-9236(95)90057-8. PMID 7586936. S2CID 19874179.
Riess, JG (2005). “Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery”. 《Artif Cells Blood Substit Immobil Biotechnol》 33 (1): 47–63. doi:10.1081/bio-200046659. PMID 15768565. S2CID 12146605.
Patel, S; Mehra, A (1998). “Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: Tissue oxygenation”. 《ASAIO J》 44 (3): 157–165. doi:10.1097/00002480-199805000-00007. PMID 9617944. S2CID 16079.
Schmidt, Walter; Prommer, Nicole (2005). “The Optimised CO-Rebreathing Method: A New Tool to Determine Total Haemogloblin Mass Routinely”. 《Eur J Appl Physiol》 95 (5–6): 486–495. doi:10.1007/s00421-005-0050-3. PMID 16222540. S2CID 1184048.
Staub, S.; 외. (2010). “Analysis of Hemoglobin-Based Oxygen Carriers by CE-UV'Vis and CE-ESI-TOF/MS”. 《Electrophoresis》 31 (7): 1241–1247. doi:10.1002/elps.200900513. PMID 20196028. S2CID 35912270.
Smith, DA; Perry, PJ (1992). “The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents”. 《Ann Pharmacother》 26 (5): 653–659. doi:10.1177/106002809202600510. PMID 1591427. S2CID 44926399.
Urhausen, Axel; Torsten, Albers; Wilfried, Kindermann (2003). “Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic–androgenic steroid abuser”. 《The Journal of Steroid Biochemistry and Molecular Biology》 84 (2–3): 369–375. doi:10.1016/s0960-0760(03)00105-5. PMID 12711025. S2CID 40408423.

smh.com.au

“Vinokourov questions French lab findings”. The Sydney Morning Herald. 2007년 7월 29일. 2007년 7월 29일에 확인함.

sueddeutsche.de

“Sportgericht urteilt gegen Pechstein”. 《sueddeutsche.de》 (독일어). 2009년 11월 25일.

tsn.ca

“Russian investigators say Cherepanov was 'doping'”. TSN. Canadian Press. 2008년 12월 29일. 2008년 12월 29일에 확인함.

uzh.ch

zora.uzh.ch

Jelkmann, W.; Lundby, C. (2011). “Blood doping and its detection” (PDF). 《Blood》 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Jelkmann, Wolfgang; Lundby, Carsten (2013). “Blood Doping and its Detection” (PDF). 《Blood》 118 (9): 2395–2402. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.

web.archive.org

“History of Doping in Sport” (PDF). International Sports Studies, Vol 24, Issue 1. 2002. 2017년 11월 23일에 원본 문서 (PDF)에서 보존된 문서. 2016년 10월 26일에 확인함.

worldcat.org

Liu, Song; Ren, Jianan; Hong, Zhiwu; Yan, Dongsheng; Gu, Guosheng; Han, Gang; Wang, Gefei; Ren, Huajian; Chen, Jun; Li, Jieshou (February 2013). “Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study”. 《Nutrition in Clinical Practice》 28 (1): 120–127. doi:10.1177/0884533612462744. ISSN 1941-2452. PMID 23064018.
Lam, Geoffrey; Zhao, Sarah; Sandhu, Jasmeet; Yi, Rong; Loganathan, Devan; Morrissey, Barbara (March 2014). “Detection of myo-inositol tris pyrophosphate (ITPP) in equine following an administration of ITPP”. 《Drug Testing and Analysis》 6 (3): 268–276. doi:10.1002/dta.1473. ISSN 1942-7611. PMID 23733541.